Condensed Consolidated Statements Of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (10,506,321)	$ (128,820)
Adjustment to reconcile net loss to net cash (used in) operating activities
Bad debt expense	627	5,980
Depreciation and amortization	10,749	31,829
Finance charge, related party	2,820,000
Gain on settlemet of debt	27,411
Gain on forgiveness of PPP loan	780,680
Non-cash compensation expense	238,634	111,248
Non-cash service expense	983,571
Issuance of Series H Pref to employee	5,000,000
(Gain)/loss on derivative liability valuation		(287,571)
Derivative expense		103,674
(Increase) Decrease in:
Accounts receivable	453,459	552,160
Prepaid expenses and other assets	4,770	(19,049)
Costs in excess of billings		129,040
Accounts payable	(730,478)	196,604
Accrued expenses	(165,811)	58,955
Customer Deposits	79,802	(576,954)
NET CASH USED IN OPERATING ACTIVITIES	(3,535,547)	(1,147,206)
CASH FLOWS FROM INVESTING ACTIVITIES:
Cash paid for purchase of fixed assets	10,930
NET CASH USED IN INVESTING ACTIVITIES	(10,930)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments on capital lease obligation		8,778
Payment of dividend	259,121
Proceeds of issuance of common stock	9,942,143
Proceeds (payments) on line of credit, net	(366,012)	336,892
Proceeds (payments) of preferred stock	(2,500)	34,775
Principal payments on debt, third party	(565,008)
Proceeds from PPP loan	780,680
Principal payments on term loan		8,917
NET CASH PROVIDED BY FINANCING ACTIVITIES	9,530,182	353,972
NET INCREASE / (DECREASE) IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH	5,983,705	(793,234)
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT BEGINNING OF PERIOD	10,538	819,328
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT END OF PERIOD	5,994,243	26,094
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	285,293	75,367
Taxes paid
Non-cash financing activities:
Conversion of notes payable to common stock	183,131	89,022
Exchange of Debt-to-Equity (Preferred)		259,698
Derivative settlement		80,357
Right of use assets	25,322	22,921
Derivative discount		87,816
Conversion of preferred to common stock	100,000
Exercise of stock options	3,529
Exercise of warrants	$ 8,556